Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.

The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, announced a new study that revealed promising results in support of further ...

Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device ...

Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.

* The Apple Watch's new HTNF algorithm now has FDA clearance to issue notifications when it detects patterns suggestive of hypertension * Over a 30-day monitoring period, it uses optical sensor //data ...

A special program developed by the University of California Health system and adopted at all six UC academic medical centers ...